Proliferative retinopathy in type 1 diabetes is associated with cerebral microbleeds, which is part of generalized microangiopathy

Diabetes Care

Volumn 37, Issue 4, 2014, Pages 1165-1168

  Woerdeman, Jorn ^a   Van Duinkerken, Eelco ^a   Wattjes, Mike P ^a   Barkhof, Frederik ^a   Snoek, Frank J ^a   Moll, Annette C ^a   Klein, Martin ^a   De Boer, Michiel P ^a   IJzerman, Richard G ^a   Serné, Erik H ^a   Diamant, Michaela ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD VESSEL FUNCTION; BRAIN HEMORRHAGE; CAPILLARY DENSITY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR ISCHEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; CEREBRAL HEMORRHAGE; COMPLICATION; MIDDLE AGED; PATHOLOGY;

ADULT; CEREBRAL HEMORRHAGE; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84897886901     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1586     Document Type: Article

References (15)

1. Gerstein HC, Ambrosius WT, Danis R, et al.; ACCORD Study Group. Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial. Diabetes Care 2013;36:1266-1271
2. Sundquist K, Li X. Type 1 diabetes as a risk factor for stroke in men and women aged 15-49: a nationwide study from Sweden. Diabet Med 2006;23:1261-1267 (Pubitemid 44600592)
3. Klein BEK, Klein R, McBride PE, et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 2004;164:1917-1924 (Pubitemid 39274363)
4. Weinger K, Jacobson AM, Musen G, et al. The effects of type 1 diabetes on cerebral white matter. Diabetologia 2008;51:417-425
5. Brands AMA, Kessels RPC, Hoogma RPLM, et al. Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes 2006;55:1800-1806 (Pubitemid 44324135)
6. Wessels AM, Scheltens P, Barkhof F, Heine RJ. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. Eur J Pharmacol 2008;585:88-96
7. van Duinkerken E, Schoonheim MM, Sanz-Arigita EJ, et al. Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables. Diabetes 2012;61:1814-1821
8. Goos JD, Henneman WJ, Sluimer JD, et al. Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population. Neurology 2010;74:1954-1960
9. Fisher M, French S, Ji P, Kim RC. Cerebral microbleeds in the elderly: a pathological analysis. Stroke 2010;41:2782-2785
10. Vernooij MW, van der Lugt A, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008;70:1208-1214 (Pubitemid 351482572)
11. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng Y-CN. Susceptibility- weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009;30:19-30
12. Mugler JP 3rd, Bao S, Mulkern RV, et al. Optimized single-slab three-dimensional spin-echo MR imaging of the brain. Radiology 2000;216:891-899 (Pubitemid 30660871)
13. Serné EH, Stehouwer CD, ter Maaten JC, et al. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 1999;99:896-902 (Pubitemid 29094303)
14. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821-1828 (Pubitemid 350044802)
15. Qiu C, Cotch MF, Sigurdsson S, et al. Retinal and cerebral microvascular signs and diabetes: the age, gene/environment susceptibility-Reykjavik study. Diabetes 2008;57:1645-1650